Labshake search
Citations for R&D Systems :
1 - 50 of 1675 citations for 7 CHLORO 10 11 DIHYDRO 5H DIBENZ B F ACEPIN 2 OL since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX; 10 μM; R&D Systems) was then added to determine the effect of AMPA receptor blockade on ePSCs ...
-
bioRxiv - Cell Biology 2020Quote: ... 10 ng/ml IL-7 (R&D Systems), 3 units/ml EPO for the second week and 10 ng/ml IL-7 and 3 units/ml EPO only for the third week ...
-
bioRxiv - Systems Biology 2021Quote: ... 10 ng/ml TGFβ (R&D Systems #240-B) + 10 ng/ml EGF.
-
bioRxiv - Cancer Biology 2021Quote: ... 1x Energy regeneration solution (#B-10 R&D systems), 75 mM ubiquitin (#U-100H R&D systems ...
-
bioRxiv - Cell Biology 2024Quote: ... TGFB 10 ng/ml (R&D Systems #240-B), EGF 10 ng/ml + OSM 10 ng/ml ...
-
bioRxiv - Immunology 2023Quote: ... IL-7 (10 ng/ml; R&D Systems, 207-IL), and TNFα (4.9 ng/ml ...
-
bioRxiv - Molecular Biology 2024Quote: ... Fecal lipocalin-2 (f-LCN2) levels were measured by R&D Systems’ ELISA kit ...
-
bioRxiv - Cell Biology 2021Quote: Isolated cardiac fibroblasts at Passage (P)2 were treated with 10 ng/mL TGF-β1 (R&D Systems Cat #240-B) in Fibroblast Growth Medium 3 for four days to assess myofibroblast differentiation ...
-
bioRxiv - Cell Biology 2020Quote: ... and 10 ng/mL TGFβ (240-B, R&D Systems). To induce mature LCs ...
-
bioRxiv - Systems Biology 2022Quote: ... and TGFβ1 (10 ng/ml, R&D Systems #240-B) + EGF (10 ng/ml) ...
-
bioRxiv - Cell Biology 2023Quote: ... recombinant human BMP4 (10 ng/ml; “B”; R&D Systems), and 100 nM retinoic acid (“Ra” ...
-
bioRxiv - Neuroscience 2022Quote: ... sonic hedgehog C25II (days 2-7, 100ng/mL, R&D Systems). After day 13 of differentiation ...
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... The single memory B cells were cultured in complete RPMI 1640 medium supplemented with IL-2 (10 U/ml, R&D Systems), IL-21 (10 U/ml ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 ng/ml TGF-β1 (240-B-010, R&D Systems) or 10ng/ml Sema3A (1250-S3-025,R&D Systems) ...
-
bioRxiv - Genomics 2024Quote: ... TGF-β1-induced (10 ng/mL) (R&D systems, #240-B) SSc fibroblasts were treated with 20 μM Ro5-3335 (TOCRIS ...
-
bioRxiv - Cancer Biology 2021Quote: ... 10 µg/mL recombinant PNGase F (9109-GH, R&D Systems; 36405.01, SERVA) and 8U PNGase F (P0704L ...
-
bioRxiv - Developmental Biology 2019Quote: ... or DMEM+10% FBS+10 ng/mL TGFβ1 (Cat. # 240-B, R&D Systems, Minneapolis, MN). A P200 tip was used scratch down the midline of every well ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems). For culture ...
-
bioRxiv - Immunology 2020Quote: ... the media were refreshed and supplemented with 5 ng/mL IL-7 or 5 ng/mL IL-7 and 4 ng/ml IL-2 (R&D Systems), respectively ...
-
bioRxiv - Cell Biology 2022Quote: ... 10 ng/mL human recombinant activin B (R&D Systems, Minneapolis, MN), 0.1 nmol/L exendin-4 (Sigma) ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100 U/mL Penicillin/Streptomycin supplemented with 0.1% recombinant human Fetal Growth Factor b (Alamone F-170) and 0.1% recombinant human Epidermal Growth Factor (R&D systems 236-EG). On Day 12 ...
-
bioRxiv - Developmental Biology 2019Quote: ... mouse IgG1 (R&D systems, 11); mouse IgG2b (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... SARS-CoV-2 B.1.1.529 S GCN4-IZ-2P (11061-CV, R&D Systems), MERS-CoV S GCN4-IZ-2P (R&D Systems) ...
-
bioRxiv - Immunology 2019Quote: ... media was supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems)(a survival factor) ...
-
bioRxiv - Immunology 2023Quote: ... in media containing 10 ng/ml IL-7 (BT-007-010; R&D Systems) at 37°C in 5% CO2 and after 3.5 days ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/ml IL-7 and 5 ng/ml IL-15 (R&D Systems). After 14 days ...
-
bioRxiv - Immunology 2022Quote: ... recombinant SARS-CoV-2 Spike RBD and recombinant SARS-CoV-2 Spike RBD B.1.617.2 L452R T478K were purchased from R&D systems. Proteins were reconstituted as per the manufacturer’s instructions.
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Molecular Biology 2019Quote: ... contains 10 mM Mg2+-ATP solution pH 7.0 (R&D systems Cat. # B-20), protease inhibitor cocktail ...
-
bioRxiv - Cell Biology 2020Quote: ... and were treated with 10 ng/mL TGF-β1 (R&D systems, 240-B) or IMRC conditioned medium where specified ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems; Bio-techne, Inc.) until use.
-
bioRxiv - Molecular Biology 2023Quote: ... Recombinant Biotin-tagged K48-linked poly-ubiquitin chains (2-7) and K48-linked poly-ubiquitin chains (2-16) were purchased from R&D Systems and Enzo Life Science ...
-
bioRxiv - Bioengineering 2020Quote: ... Mouse IL-28 A/B (IFN-lambda 2/3) Du-oSet ELISA (DY1789B, R&D Systems), was used to assess cross-reactivity.
-
bioRxiv - Immunology 2021Quote: ... IL-11 was quantified by using a Human IL-11 Quantikine ELISA Kit according to manufacturer instructions (R&D Systems). Statistical analysis was performed on log10-transformed values with two-way ANOVA tests and Tukey correction ...
-
bioRxiv - Immunology 2020Quote: ... Collected ILCs were rested in 10ng/mL IL-2 and IL-7 (R&D Systems, Minneapolis, MN) in T-cell media (TCM ...
-
bioRxiv - Cell Biology 2023Quote: ... cells were treated with or without 10 ng/ml TGFβ (R&D Systems, Cat. # 240-B) for another 24 hr and harvested for RNA extraction after 72 hr.
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-10 ...
-
Optimization of AAV6 transduction enhances site-specific genome editing of primary human lymphocytesbioRxiv - Molecular Biology 2021Quote: ... 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-6 (Peprotech) ...
-
bioRxiv - Genetics 2019Quote: ... 10 ng/ml FGF-2 (R&D Systems)] ...
-
bioRxiv - Immunology 2023Quote: ... 10 ng/mL IL-2 (R&D Systems), 50 ng/mL IL-10 ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Genetics 2023Quote: ... and receptor activator of nuclear factor kappa-B ligand (RANKL) (2 ng/mL; R&D systems; USA) to induce osteoclastogenesis ...
-
An endothelial SOX18-mevalonate pathway axis enables repurposing of statins for infantile hemangiomabioRxiv - Molecular Biology 2024Quote: ... The medium was replaced with fresh differentiation medium containing 10 ng/mL VEGF-B (R&D Systems) every two days ...
-
bioRxiv - Cell Biology 2022Quote: ... Both mouse and mixed organoids were exposed to recombinant human IL-11 (rhIL-11, R&D systems, Minneapolis, MN, USA, #218-IL) during the entire organoid culture period of 14 days.
-
bioRxiv - Immunology 2023Quote: ... IL-11 (5ng/mL, R&D Systems, 218-IL), TPO (30ng/mL ...
-
bioRxiv - Cell Biology 2020Quote: ... to RAW264.7 or 2 ng/mL transforming growth factor β-1(240-B/CF, R&D System, USA) to THP-1 for 24-36 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Cancer Biology 2023Quote: ... mIL-2 (10 ng/ml; R&D Systems Inc) was added to the culture medium from day 1 to expand iTregs ...
-
bioRxiv - Bioengineering 2019Quote: ... and 10 ng/ml fibroblast growth factor-2 (FGF-2, R&D Systems, Minneapolis, MN) (39 ...